Dr. Roozbeh Behroozmand's research lab at the University of Texas Dallas focuses on understanding vocal communication disorders, specifically aphasia, which often arises from strokes. The lab investigates the neural mechanisms behind these communication impairments and aims to develop targeted therapies using advanced imaging and neurophysiological techniques. By integrating auditory and visual feedback methods, the lab seeks to improve treatment outcomes for individuals with aphasia, ultimately enhancing their quality of life.

Dr. Noa Ofen's research lab at the University of Texas Dallas studies how children develop memory skills and the brain processes involved. They use advanced techniques like intracranial EEG and fMRI to understand how memory retrieval works in children, especially those with epilepsy. By delving into the brain’s memory networks, the lab aims to create effective interventions for memory problems in children, potentially improving their quality of life.

Dr. Theodore Price's research lab focuses on understanding the molecular mechanisms behind chronic pain using human tissue samples. By analyzing the first neurons in the pain pathway, they aim to develop new therapeutic targets for pain management. The lab uses innovative techniques like CRISPR screening to conduct functional genomic studies, connecting molecular findings to real human pain conditions.

Dr. Rudi Fasan's lab at the University of Texas Dallas focuses on creating new methods for discovering and synthesizing bioactive molecules, especially cyclic peptides, which can modulate biomolecular interactions with high precision. Their innovative approaches combine chemistry and biology to develop new catalysts and platforms that streamline drug discovery processes and enhance our understanding of complex biological systems.

Dr. Xintong Dong's lab at the University of Texas Dallas focuses on understanding how the body defends against urinary tract infections (UTIs) caused by bacteria. The lab works on a type of immune molecule called defensins to see how they protect the urinary tract and potentially cause discomfort. By using advanced genetic techniques and mouse models, the lab aims to develop new therapies to improve outcomes for patients suffering from UTIs and the pain they may cause.

Dr. Yongsheng Gao's lab at the University of Texas Dallas is focused on developing innovative synthetic materials to help manage traumatic bleeding in emergency situations. By creating microgel-based synthetic platelets that mimic the properties of natural platelets, the lab aims to improve the way we stop bleeding at injury sites. This research has significant implications for trauma care, potentially saving lives in critical situations.

Yannick Fotio's lab at the University of Texas Dallas focuses on understanding the biological mechanisms behind chronic pain, a significant health issue affecting millions. The research investigates the role of a specific enzyme, N-Acylethanolamine Acid Amidase (NAAA), in pain signaling and how it may contribute to the transition from acute to chronic pain. By exploring metabolic changes in cells after injury, the lab aims to uncover novel therapeutic targets for managing chronic pain.

Dr. Amy Pinkham's lab at the University of Texas Dallas focuses on understanding social cognition in individuals at high risk for psychosis. The research aims to develop and validate sensitive measures of social cognition that can help identify people at risk of developing psychotic disorders. This work is essential for improving treatment strategies and understanding how social cognitive performance relates to real-world outcomes for young individuals facing these challenges.

Dr. Zhenpeng Qin's lab at the University of Texas Dallas focuses on innovative methods for delivering therapeutic molecules specifically to neurons and spinal cord tumors. By developing a peptide that can target neurons across various animal species and employing light-based techniques to modulate the blood-spinal cord barrier, the lab aims to enhance drug delivery for neurological diseases and cancers affecting the spinal cord. This work has significant implications for improving treatment options and understanding of central nervous system disorders.

Dr. Adrianna Shembel's research lab at the University of Texas Dallas focuses on understanding and improving voice disorders, particularly those related to muscle tension and nerve injuries affecting the larynx. Her lab combines innovative techniques like motion capture and electrical stimulation to explore how to restore vocal function and address communication issues resulting from injuries and disorders. The goal is to identify new treatment methods that can enhance the quality of life for individuals suffering from these conditions.

Dr. Robert Rennaker's lab focuses on improving recovery after spinal cord injuries, particularly in restoring walking abilities. They utilize a technique called vagus nerve stimulation alongside rehabilitation exercises to promote healing and functional recovery in patients. The lab is involved in clinical trials to evaluate the effectiveness of these innovative therapies in helping individuals regain mobility and improve their quality of life.

David W Schmidtke's research lab at the University of Texas Dallas focuses on understanding how the immune system behaves in patients with ventricular assist devices (VADs) who are at risk for infections. They aim to identify biomarkers that predict infections and develop innovative tools to assess immune function in these patients. The lab's goal is to improve patient outcomes by exploring new therapies that can enhance the immune response and reduce infection rates in individuals with heart failure.

Dr. Michael D Rugg's lab at the University of Texas Dallas focuses on understanding how memory declines with aging, particularly episodic memory, which is the ability to recall specific events. The lab conducts research using advanced brain imaging techniques to explore the changes in brain activity related to memory as people age. Their goal is to identify neural factors that contribute to memory decline to pave the way for new interventions to improve memory in older adults and those at risk for Alzheimer’s disease.

Dr. Muhammad Saad Yousuf's lab focuses on understanding and treating diabetic neuropathic pain, a common and often debilitating condition affecting people with diabetes. The research explores how a molecule called methylglyoxal impacts nerve cells, leading to increased pain sensitivity. By using both animal models and human neurons, the lab aims to develop non-opioid treatments targeting specific stress-response pathways involved in pain.